Cataract is identified as a leading cause of visual impairment globally and surgery is the only effective treatment. The European Society of Cataract and Refractive Surgeons (ESCRS) produced an evidence-based guideline to support decision-making across the entire cataract care pathway, including screening, patient selection, preoperative assessment, the surgical episode, and postoperative follow-up. The executive summary presents principal recommendations intended for clinicians, patients, and healthcare stakeholders.
A multidisciplinary panel assembled by ESCRS developed the guideline with methodological support. The panel used the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach to appraise evidence and formulate recommendations. The working group included ophthalmologists and other experts from multiple European centers; the document addresses 32 key clinical questions relevant to routine cataract practice and service organization.
The guideline addresses 32 clinical questions spanning infection prevention, anesthesia, refractive planning, surgical technique selection, anti-inflammatory strategies, and service delivery. Recommendations focus on interventions demonstrated or judged to improve outcomes, reduce complications, or increase efficiency in cataract services. The summary highlights core practical recommendations; detailed evidence gradings and supporting data are provided in the full guideline.
To reduce the risk of postoperative endophthalmitis, the guideline recommends the use of intracameral antibiotics at the conclusion of cataract surgery. This recommendation is presented as a key measure for infection prevention within the surgical pathway. Specific antibiotic agents, dosing regimens, and local regulatory considerations were not detailed in the executive summary and should be consulted in the full guideline.
The panel recommends topical anesthesia as the preferred technique for routine cataract surgery. Topical anesthesia is favored for its safety profile and suitability in the majority of uncomplicated cataract procedures. The executive summary does not provide granular technique protocols or contraindications, which are expected to be covered in the main guideline.
For eyes with clinically relevant corneal astigmatism, the guideline recommends implantation of toric intraocular lenses (IOLs) when corneal astigmatism is at or above 1.0 diopter. The document emphasizes shared decision-making with patients regarding lens selection, aligning refractive goals, visual expectations, and the risks and benefits of different IOL options.
The guideline reports that conventional phacoemulsification and femtosecond laser–assisted cataract surgery are comparably safe and effective based on the evidence reviewed. The executive summary indicates no clear superiority of one technique over the other in general safety and effectiveness but does not replace individualized choice based on patient factors, surgeon expertise, and resource availability.
To reduce postoperative inflammation and lower the risk of cystoid macular edema (CME), the panel recommends the use of nonsteroidal anti-inflammatory drug (NSAID) eyedrops, either alone or in combination with topical corticosteroids. The guideline supports NSAID use as an important element of postoperative pharmacologic prophylaxis. Specific drug choices, timing, duration, and patient selection criteria are addressed in the full guideline rather than the executive summary.
The guideline provides guidance on service delivery models to enhance efficiency and patient access. It supports the safe use of immediate sequential bilateral cataract surgery in selected patients when appropriate safeguards and informed consent are in place. The summary also highlights the potential role of remote postoperative care (telemedicine or remote monitoring) as a means to increase service efficiency and optimize resource use, while noting that implementation should consider local systems and patient safety.
The ESCRS guideline aims to improve clinical outcomes, patient experience, and the organization of cataract services. Recommendations are intended to help clinicians, patients, and healthcare managers make informed choices about interventions across the care pathway. The executive summary presents key practice points; full implementation details, evidence gradings for individual statements, and operational recommendations are provided in the complete guideline document.
Note: This summary is based solely on the executive summary text of the ESCRS guideline as presented in the cited PubMed record. Where the executive summary did not report specific agent names, dosages, or detailed protocols, those details are not included here and should be consulted in the full guideline publication.